Global Metabolic Disorders Drugs Industry Research Report, Competitive Landscape, Market Size, Regional Status and Prospect
A metabolic disorder can happen when abnormal chemical reactions in the body alter the normal metabolic process. It can also be defined as inherited single gene anomaly, most of which are autosomal recessive.
The report combines extensive quantitative analysis and exhaustive qualitative analysis, ranges from a macro overview of the total market size, industry chain, and market dynamics to micro details of segment markets by type, application and region, and, as a result, provides a holistic view of, as well as a deep insight into the Metabolic Disorders Drugs market covering all its essential aspects.
For the competitive landscape, the report also introduces players in the industry from the perspective of the market share, concentration ratio, etc., and describes the leading companies in detail, with which the readers can get a better idea of their competitors and acquire an in-depth understanding of the competitive situation. Further, mergers & acquisitions, emerging market trends, the impact of COVID-19, and regional conflicts will all be considered.
In a nutshell, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the market in any manner.
Key players in the global Metabolic Disorders Drugs market are covered in Chapter 9:
Zafgen
Mitobridge
Biophytis
OxThera
CellCentric
Eternygen
Rhythm
Verva Pharmaceuticals
PerkinElmer
Pronutria Biosciences
Anchor Therapeutics
Outpost Medicine
Nimbus Therapeutics
MedGenome
Biophytis
Zealand Pharma
Exelixis, Inc.
In Chapter 5 and Chapter 7.3, based on types, the Metabolic Disorders Drugs market from 2017 to 2027 is primarily split into:
Tablet
Injection
In Chapter 6 and Chapter 7.4, based on applications, the Metabolic Disorders Drugs market from 2017 to 2027 covers:
Diabetes
Disorders of the Thyroid and Pituitary Gland
Other
Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historical data and forecast (2017-2027) of the following regions are covered in Chapter 4 and Chapter 7:
United States
Europe
China
Japan
India
Southeast Asia
Latin America
Middle East and Africa
Client Focus
1. Does this report consider the impact of COVID-19 and the Russia-Ukraine war on the Metabolic Disorders Drugs market?
Yes. As the COVID-19 and the Russia-Ukraine war are profoundly affecting the global supply chain relationship and raw material price system, we have definitely taken them into consideration throughout the research, and in Chapters 1.7, 2.7, 4.X.1, 7.5, 8.7, we elaborate at full length on the impact of the pandemic and the war on the Metabolic Disorders Drugs Industry.
2. How do you determine the list of the key players included in the report?
With the aim of clearly revealing the competitive situation of the industry, we concretely analyze not only the leading enterprises that have a voice on a global scale, but also the regional small and medium-sized companies that play key roles and have plenty of potential growth.
Please find the key player list in Summary.
3. What are your main data sources?
Both Primary and Secondary data sources are being used while compiling the report.
Primary sources include extensive interviews of key opinion leaders and industry experts (such as experienced front-line staff, directors, CEOs, and marketing executives), downstream distributors, as well as end-users.
Secondary sources include the research of the annual and financial reports of the top companies, public files, new journals, etc. We also cooperate with some third-party databases.
Please find a more complete list of data sources in Chapters 11.2.1 & 11.2.2.
4. Can I modify the scope of the report and customize it to suit my requirements?
Yes. Customized requirements of multi-dimensional, deep-level and high-quality can help our customers precisely grasp market opportunities, effortlessly confront market challenges, properly formulate market strategies and act promptly, thus to win them sufficient time and space for market competition.
Outline
Chapter 1 mainly defines the market scope and introduces the macro overview of the industry, with an executive summary of different market segments ((by type, application, region, etc.), including the definition, market size, and trend of each market segment.
Chapter 2 provides a qualitative analysis of the current status and future trends of the market. Industry Entry Barriers, market drivers, market challenges, emerging markets, consumer preference analysis, together with the impact of the COVID-19 outbreak will all be thoroughly explained.
Chapter 3 analyzes the current competitive situation of the market by providing data regarding the players, including their sales volume and revenue with corresponding market shares, price and gross margin. In addition, information about market concentration ratio, mergers, acquisitions, and expansion plans will also be covered.
Chapter 4 focuses on the regional market, presenting detailed data (i.e., sales volume, revenue, price, gross margin) of the most representative regions and countries in the world.
Chapter 5 provides the analysis of various market segments according to product types, covering sales volume, revenue along with market share and growth rate, plus the price analysis of each type.
Chapter 6 shows the breakdown data of different applications, including the consumption and revenue with market share and growth rate, with the aim of helping the readers to take a close-up look at the downstream market.
Chapter 7 provides a combination of quantitative and qualitative analyses of the market size and development trends in the next five years. The forecast information of the whole, as well as the breakdown market, offers the readers a chance to look into the future of the industry.
Chapter 8 is the analysis of the whole market industrial chain, covering key raw materials suppliers and price analysis, manufacturing cost structure analysis, alternative product analysis, also providing information on major distributors, downstream buyers, and the impact of COVID-19 pandemic.
Chapter 9 shares a list of the key players in the market, together with their basic information, product profiles, market performance (i.e., sales volume, price, revenue, gross margin), recent development, SWOT analysis, etc.
Chapter 10 is the conclusion of the report which helps the readers to sum up the main findings and points.
Chapter 11 introduces the market research methods and data sources.
Years considered for this report:
Historical Years: 2017-2021
Base Year: 2021
Estimated Year: 2022
Forecast Period: 2022-2027
1 METABOLIC DISORDERS DRUGS MARKET OVERVIEW
1.1 Product Overview and Scope of Metabolic Disorders Drugs Market
1.2 Metabolic Disorders Drugs Market Segment by Type
1.2.1 Global Metabolic Disorders Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Metabolic Disorders Drugs Market Segment by Application
1.3.1 Metabolic Disorders Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Metabolic Disorders Drugs Market, Region Wise (2017-2027)
1.4.1 Global Metabolic Disorders Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.4 China Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.6 India Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Metabolic Disorders Drugs (2017-2027)
1.5.1 Global Metabolic Disorders Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Metabolic Disorders Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Metabolic Disorders Drugs Market
2 INDUSTRY OUTLOOK
2.1 Metabolic Disorders Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Metabolic Disorders Drugs Market Drivers Analysis
2.4 Metabolic Disorders Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Metabolic Disorders Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Metabolic Disorders Drugs Industry Development
3 GLOBAL METABOLIC DISORDERS DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Metabolic Disorders Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Metabolic Disorders Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Metabolic Disorders Drugs Average Price by Player (2017-2022)
3.4 Global Metabolic Disorders Drugs Gross Margin by Player (2017-2022)
3.5 Metabolic Disorders Drugs Market Competitive Situation and Trends
3.5.1 Metabolic Disorders Drugs Market Concentration Rate
3.5.2 Metabolic Disorders Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL METABOLIC DISORDERS DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Metabolic Disorders Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Metabolic Disorders Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Metabolic Disorders Drugs Market Under COVID-19
4.5 Europe Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Metabolic Disorders Drugs Market Under COVID-19
4.6 China Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Metabolic Disorders Drugs Market Under COVID-19
4.7 Japan Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Metabolic Disorders Drugs Market Under COVID-19
4.8 India Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Metabolic Disorders Drugs Market Under COVID-19
4.9 Southeast Asia Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Metabolic Disorders Drugs Market Under COVID-19
4.10 Latin America Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Metabolic Disorders Drugs Market Under COVID-19
4.11 Middle East and Africa Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Metabolic Disorders Drugs Market Under COVID-19
5 GLOBAL METABOLIC DISORDERS DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Metabolic Disorders Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Metabolic Disorders Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Metabolic Disorders Drugs Price by Type (2017-2022)
5.4 Global Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate of Tablet (2017-2022)
5.4.2 Global Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate of Injection (2017-2022)
6 GLOBAL METABOLIC DISORDERS DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Metabolic Disorders Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Metabolic Disorders Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Metabolic Disorders Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Metabolic Disorders Drugs Consumption and Growth Rate of Diabetes (2017-2022)
6.3.2 Global Metabolic Disorders Drugs Consumption and Growth Rate of Disorders of the Thyroid and Pituitary Gland (2017-2022)
6.3.3 Global Metabolic Disorders Drugs Consumption and Growth Rate of Other (2017-2022)
7 GLOBAL METABOLIC DISORDERS DRUGS MARKET FORECAST (2022-2027)
7.1 Global Metabolic Disorders Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Metabolic Disorders Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Metabolic Disorders Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Metabolic Disorders Drugs Price and Trend Forecast (2022-2027)
7.2 Global Metabolic Disorders Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Metabolic Disorders Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Metabolic Disorders Drugs Revenue and Growth Rate of Tablet (2022-2027)
7.3.2 Global Metabolic Disorders Drugs Revenue and Growth Rate of Injection (2022-2027)
7.4 Global Metabolic Disorders Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Metabolic Disorders Drugs Consumption Value and Growth Rate of Diabetes(2022-2027)
7.4.2 Global Metabolic Disorders Drugs Consumption Value and Growth Rate of Disorders of the Thyroid and Pituitary Gland(2022-2027)
7.4.3 Global Metabolic Disorders Drugs Consumption Value and Growth Rate of Other(2022-2027)
7.5 Metabolic Disorders Drugs Market Forecast Under COVID-19
8 METABOLIC DISORDERS DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Metabolic Disorders Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Metabolic Disorders Drugs Analysis
8.6 Major Downstream Buyers of Metabolic Disorders Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Metabolic Disorders Drugs Industry
9 PLAYERS PROFILES
9.1 Zafgen
9.1.1 Zafgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.1.3 Zafgen Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Mitobridge
9.2.1 Mitobridge Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.2.3 Mitobridge Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Biophytis
9.3.1 Biophytis Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.3.3 Biophytis Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 OxThera
9.4.1 OxThera Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.4.3 OxThera Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 CellCentric
9.5.1 CellCentric Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.5.3 CellCentric Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Eternygen
9.6.1 Eternygen Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.6.3 Eternygen Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Rhythm
9.7.1 Rhythm Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.7.3 Rhythm Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Verva Pharmaceuticals
9.8.1 Verva Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.8.3 Verva Pharmaceuticals Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 PerkinElmer
9.9.1 PerkinElmer Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.9.3 PerkinElmer Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Pronutria Biosciences
9.10.1 Pronutria Biosciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.10.3 Pronutria Biosciences Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Anchor Therapeutics
9.11.1 Anchor Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.11.3 Anchor Therapeutics Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Outpost Medicine
9.12.1 Outpost Medicine Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.12.3 Outpost Medicine Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Nimbus Therapeutics
9.13.1 Nimbus Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.13.3 Nimbus Therapeutics Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 MedGenome
9.14.1 MedGenome Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.14.3 MedGenome Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Biophytis
9.15.1 Biophytis Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.15.3 Biophytis Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Zealand Pharma
9.16.1 Zealand Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.16.3 Zealand Pharma Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Exelixis, Inc.
9.17.1 Exelixis, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.17.3 Exelixis, Inc. Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
1.1 Product Overview and Scope of Metabolic Disorders Drugs Market
1.2 Metabolic Disorders Drugs Market Segment by Type
1.2.1 Global Metabolic Disorders Drugs Market Sales Volume and CAGR (%) Comparison by Type (2017-2027)
1.3 Global Metabolic Disorders Drugs Market Segment by Application
1.3.1 Metabolic Disorders Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
1.4 Global Metabolic Disorders Drugs Market, Region Wise (2017-2027)
1.4.1 Global Metabolic Disorders Drugs Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2027)
1.4.2 United States Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.3 Europe Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.4 China Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.5 Japan Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.6 India Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.7 Southeast Asia Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.8 Latin America Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.4.9 Middle East and Africa Metabolic Disorders Drugs Market Status and Prospect (2017-2027)
1.5 Global Market Size of Metabolic Disorders Drugs (2017-2027)
1.5.1 Global Metabolic Disorders Drugs Market Revenue Status and Outlook (2017-2027)
1.5.2 Global Metabolic Disorders Drugs Market Sales Volume Status and Outlook (2017-2027)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Metabolic Disorders Drugs Market
2 INDUSTRY OUTLOOK
2.1 Metabolic Disorders Drugs Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Metabolic Disorders Drugs Market Drivers Analysis
2.4 Metabolic Disorders Drugs Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Metabolic Disorders Drugs Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Metabolic Disorders Drugs Industry Development
3 GLOBAL METABOLIC DISORDERS DRUGS MARKET LANDSCAPE BY PLAYER
3.1 Global Metabolic Disorders Drugs Sales Volume and Share by Player (2017-2022)
3.2 Global Metabolic Disorders Drugs Revenue and Market Share by Player (2017-2022)
3.3 Global Metabolic Disorders Drugs Average Price by Player (2017-2022)
3.4 Global Metabolic Disorders Drugs Gross Margin by Player (2017-2022)
3.5 Metabolic Disorders Drugs Market Competitive Situation and Trends
3.5.1 Metabolic Disorders Drugs Market Concentration Rate
3.5.2 Metabolic Disorders Drugs Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion
4 GLOBAL METABOLIC DISORDERS DRUGS SALES VOLUME AND REVENUE REGION WISE (2017-2022)
4.1 Global Metabolic Disorders Drugs Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Metabolic Disorders Drugs Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Metabolic Disorders Drugs Market Under COVID-19
4.5 Europe Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Metabolic Disorders Drugs Market Under COVID-19
4.6 China Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Metabolic Disorders Drugs Market Under COVID-19
4.7 Japan Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Metabolic Disorders Drugs Market Under COVID-19
4.8 India Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Metabolic Disorders Drugs Market Under COVID-19
4.9 Southeast Asia Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Metabolic Disorders Drugs Market Under COVID-19
4.10 Latin America Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Metabolic Disorders Drugs Market Under COVID-19
4.11 Middle East and Africa Metabolic Disorders Drugs Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Metabolic Disorders Drugs Market Under COVID-19
5 GLOBAL METABOLIC DISORDERS DRUGS SALES VOLUME, REVENUE, PRICE TREND BY TYPE
5.1 Global Metabolic Disorders Drugs Sales Volume and Market Share by Type (2017-2022)
5.2 Global Metabolic Disorders Drugs Revenue and Market Share by Type (2017-2022)
5.3 Global Metabolic Disorders Drugs Price by Type (2017-2022)
5.4 Global Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate of Tablet (2017-2022)
5.4.2 Global Metabolic Disorders Drugs Sales Volume, Revenue and Growth Rate of Injection (2017-2022)
6 GLOBAL METABOLIC DISORDERS DRUGS MARKET ANALYSIS BY APPLICATION
6.1 Global Metabolic Disorders Drugs Consumption and Market Share by Application (2017-2022)
6.2 Global Metabolic Disorders Drugs Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Metabolic Disorders Drugs Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Metabolic Disorders Drugs Consumption and Growth Rate of Diabetes (2017-2022)
6.3.2 Global Metabolic Disorders Drugs Consumption and Growth Rate of Disorders of the Thyroid and Pituitary Gland (2017-2022)
6.3.3 Global Metabolic Disorders Drugs Consumption and Growth Rate of Other (2017-2022)
7 GLOBAL METABOLIC DISORDERS DRUGS MARKET FORECAST (2022-2027)
7.1 Global Metabolic Disorders Drugs Sales Volume, Revenue Forecast (2022-2027)
7.1.1 Global Metabolic Disorders Drugs Sales Volume and Growth Rate Forecast (2022-2027)
7.1.2 Global Metabolic Disorders Drugs Revenue and Growth Rate Forecast (2022-2027)
7.1.3 Global Metabolic Disorders Drugs Price and Trend Forecast (2022-2027)
7.2 Global Metabolic Disorders Drugs Sales Volume and Revenue Forecast, Region Wise (2022-2027)
7.2.1 United States Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.2 Europe Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.3 China Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.4 Japan Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.5 India Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.6 Southeast Asia Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.7 Latin America Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.2.8 Middle East and Africa Metabolic Disorders Drugs Sales Volume and Revenue Forecast (2022-2027)
7.3 Global Metabolic Disorders Drugs Sales Volume, Revenue and Price Forecast by Type (2022-2027)
7.3.1 Global Metabolic Disorders Drugs Revenue and Growth Rate of Tablet (2022-2027)
7.3.2 Global Metabolic Disorders Drugs Revenue and Growth Rate of Injection (2022-2027)
7.4 Global Metabolic Disorders Drugs Consumption Forecast by Application (2022-2027)
7.4.1 Global Metabolic Disorders Drugs Consumption Value and Growth Rate of Diabetes(2022-2027)
7.4.2 Global Metabolic Disorders Drugs Consumption Value and Growth Rate of Disorders of the Thyroid and Pituitary Gland(2022-2027)
7.4.3 Global Metabolic Disorders Drugs Consumption Value and Growth Rate of Other(2022-2027)
7.5 Metabolic Disorders Drugs Market Forecast Under COVID-19
8 METABOLIC DISORDERS DRUGS MARKET UPSTREAM AND DOWNSTREAM ANALYSIS
8.1 Metabolic Disorders Drugs Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Metabolic Disorders Drugs Analysis
8.6 Major Downstream Buyers of Metabolic Disorders Drugs Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Metabolic Disorders Drugs Industry
9 PLAYERS PROFILES
9.1 Zafgen
9.1.1 Zafgen Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.1.3 Zafgen Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Mitobridge
9.2.1 Mitobridge Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.2.3 Mitobridge Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Biophytis
9.3.1 Biophytis Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.3.3 Biophytis Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 OxThera
9.4.1 OxThera Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.4.3 OxThera Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 CellCentric
9.5.1 CellCentric Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.5.3 CellCentric Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Eternygen
9.6.1 Eternygen Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.6.3 Eternygen Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Rhythm
9.7.1 Rhythm Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.7.3 Rhythm Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Verva Pharmaceuticals
9.8.1 Verva Pharmaceuticals Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.8.3 Verva Pharmaceuticals Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 PerkinElmer
9.9.1 PerkinElmer Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.9.3 PerkinElmer Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Pronutria Biosciences
9.10.1 Pronutria Biosciences Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.10.3 Pronutria Biosciences Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 Anchor Therapeutics
9.11.1 Anchor Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.11.3 Anchor Therapeutics Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Outpost Medicine
9.12.1 Outpost Medicine Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.12.3 Outpost Medicine Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 Nimbus Therapeutics
9.13.1 Nimbus Therapeutics Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.13.3 Nimbus Therapeutics Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 MedGenome
9.14.1 MedGenome Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.14.3 MedGenome Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 Biophytis
9.15.1 Biophytis Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.15.3 Biophytis Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis
9.16 Zealand Pharma
9.16.1 Zealand Pharma Basic Information, Manufacturing Base, Sales Region and Competitors
9.16.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.16.3 Zealand Pharma Market Performance (2017-2022)
9.16.4 Recent Development
9.16.5 SWOT Analysis
9.17 Exelixis, Inc.
9.17.1 Exelixis, Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.17.2 Metabolic Disorders Drugs Product Profiles, Application and Specification
9.17.3 Exelixis, Inc. Market Performance (2017-2022)
9.17.4 Recent Development
9.17.5 SWOT Analysis
10 RESEARCH FINDINGS AND CONCLUSION
11 APPENDIX
11.1 Methodology
11.2 Research Data Source
LIST OF TABLES AND FIGURES
Figure Metabolic Disorders Drugs Product Picture
Table Global Metabolic Disorders Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Metabolic Disorders Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Metabolic Disorders Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Metabolic Disorders Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Metabolic Disorders Drugs Industry Development
Table Global Metabolic Disorders Drugs Sales Volume by Player (2017-2022)
Table Global Metabolic Disorders Drugs Sales Volume Share by Player (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Share by Player in 2021
Table Metabolic Disorders Drugs Revenue (Million USD) by Player (2017-2022)
Table Metabolic Disorders Drugs Revenue Market Share by Player (2017-2022)
Table Metabolic Disorders Drugs Price by Player (2017-2022)
Table Metabolic Disorders Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Metabolic Disorders Drugs Sales Volume, Region Wise (2017-2022)
Table Global Metabolic Disorders Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Metabolic Disorders Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Metabolic Disorders Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue Market Share, Region Wise in 2021
Table Global Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Metabolic Disorders Drugs Sales Volume by Type (2017-2022)
Table Global Metabolic Disorders Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Market Share by Type in 2021
Table Global Metabolic Disorders Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Metabolic Disorders Drugs Revenue Market Share by Type (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue Market Share by Type in 2021
Table Metabolic Disorders Drugs Price by Type (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume and Growth Rate of Tablet (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Tablet (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume and Growth Rate of Injection (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Injection (2017-2022)
Table Global Metabolic Disorders Drugs Consumption by Application (2017-2022)
Table Global Metabolic Disorders Drugs Consumption Market Share by Application (2017-2022)
Table Global Metabolic Disorders Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Metabolic Disorders Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Metabolic Disorders Drugs Consumption and Growth Rate of Diabetes (2017-2022)
Table Global Metabolic Disorders Drugs Consumption and Growth Rate of Disorders of the Thyroid and Pituitary Gland (2017-2022)
Table Global Metabolic Disorders Drugs Consumption and Growth Rate of Other (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Metabolic Disorders Drugs Price and Trend Forecast (2022-2027)
Figure USA Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Metabolic Disorders Drugs Market Sales Volume Forecast, by Type
Table Global Metabolic Disorders Drugs Sales Volume Market Share Forecast, by Type
Table Global Metabolic Disorders Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Metabolic Disorders Drugs Revenue Market Share Forecast, by Type
Table Global Metabolic Disorders Drugs Price Forecast, by Type
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Tablet (2022-2027)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Tablet (2022-2027)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Injection (2022-2027)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Injection (2022-2027)
Table Global Metabolic Disorders Drugs Market Consumption Forecast, by Application
Table Global Metabolic Disorders Drugs Consumption Market Share Forecast, by Application
Table Global Metabolic Disorders Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Metabolic Disorders Drugs Revenue Market Share Forecast, by Application
Figure Global Metabolic Disorders Drugs Consumption Value (Million USD) and Growth Rate of Diabetes (2022-2027)
Figure Global Metabolic Disorders Drugs Consumption Value (Million USD) and Growth Rate of Disorders of the Thyroid and Pituitary Gland (2022-2027)
Figure Global Metabolic Disorders Drugs Consumption Value (Million USD) and Growth Rate of Other (2022-2027)
Figure Metabolic Disorders Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Zafgen Profile
Table Zafgen Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Zafgen Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Zafgen Revenue (Million USD) Market Share 2017-2022
Table Mitobridge Profile
Table Mitobridge Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mitobridge Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Mitobridge Revenue (Million USD) Market Share 2017-2022
Table Biophytis Profile
Table Biophytis Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biophytis Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Biophytis Revenue (Million USD) Market Share 2017-2022
Table OxThera Profile
Table OxThera Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure OxThera Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure OxThera Revenue (Million USD) Market Share 2017-2022
Table CellCentric Profile
Table CellCentric Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CellCentric Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure CellCentric Revenue (Million USD) Market Share 2017-2022
Table Eternygen Profile
Table Eternygen Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eternygen Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Eternygen Revenue (Million USD) Market Share 2017-2022
Table Rhythm Profile
Table Rhythm Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Rhythm Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Rhythm Revenue (Million USD) Market Share 2017-2022
Table Verva Pharmaceuticals Profile
Table Verva Pharmaceuticals Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Verva Pharmaceuticals Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Verva Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table PerkinElmer Profile
Table PerkinElmer Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PerkinElmer Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure PerkinElmer Revenue (Million USD) Market Share 2017-2022
Table Pronutria Biosciences Profile
Table Pronutria Biosciences Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pronutria Biosciences Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Pronutria Biosciences Revenue (Million USD) Market Share 2017-2022
Table Anchor Therapeutics Profile
Table Anchor Therapeutics Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Anchor Therapeutics Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Anchor Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Outpost Medicine Profile
Table Outpost Medicine Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Outpost Medicine Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Outpost Medicine Revenue (Million USD) Market Share 2017-2022
Table Nimbus Therapeutics Profile
Table Nimbus Therapeutics Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nimbus Therapeutics Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Nimbus Therapeutics Revenue (Million USD) Market Share 2017-2022
Table MedGenome Profile
Table MedGenome Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure MedGenome Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure MedGenome Revenue (Million USD) Market Share 2017-2022
Table Biophytis Profile
Table Biophytis Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biophytis Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Biophytis Revenue (Million USD) Market Share 2017-2022
Table Zealand Pharma Profile
Table Zealand Pharma Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Zealand Pharma Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Zealand Pharma Revenue (Million USD) Market Share 2017-2022
Table Exelixis, Inc. Profile
Table Exelixis, Inc. Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Exelixis, Inc. Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Exelixis, Inc. Revenue (Million USD) Market Share 2017-2022
Figure Metabolic Disorders Drugs Product Picture
Table Global Metabolic Disorders Drugs Market Sales Volume and CAGR (%) Comparison by Type
Table Metabolic Disorders Drugs Market Consumption (Sales Volume) Comparison by Application (2017-2027)
Figure Global Metabolic Disorders Drugs Market Size (Revenue, Million USD) and CAGR (%) (2017-2027)
Figure United States Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Europe Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure China Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Japan Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure India Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Southeast Asia Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Latin America Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Middle East and Africa Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate (2017-2027)
Figure Global Metabolic Disorders Drugs Market Sales Volume Status and Outlook (2017-2027)
Table Global Macroeconomic Analysis
Figure Global COVID-19 Status Overview
Table Influence of COVID-19 Outbreak on Metabolic Disorders Drugs Industry Development
Table Global Metabolic Disorders Drugs Sales Volume by Player (2017-2022)
Table Global Metabolic Disorders Drugs Sales Volume Share by Player (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Share by Player in 2021
Table Metabolic Disorders Drugs Revenue (Million USD) by Player (2017-2022)
Table Metabolic Disorders Drugs Revenue Market Share by Player (2017-2022)
Table Metabolic Disorders Drugs Price by Player (2017-2022)
Table Metabolic Disorders Drugs Gross Margin by Player (2017-2022)
Table Mergers & Acquisitions, Expansion Plans
Table Global Metabolic Disorders Drugs Sales Volume, Region Wise (2017-2022)
Table Global Metabolic Disorders Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Market Share, Region Wise (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Market Share, Region Wise in 2021
Table Global Metabolic Disorders Drugs Revenue (Million USD), Region Wise (2017-2022)
Table Global Metabolic Disorders Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue Market Share, Region Wise (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue Market Share, Region Wise in 2021
Table Global Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table United States Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Europe Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table China Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Japan Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table India Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Southeast Asia Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Latin America Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Middle East and Africa Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Table Global Metabolic Disorders Drugs Sales Volume by Type (2017-2022)
Table Global Metabolic Disorders Drugs Sales Volume Market Share by Type (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume Market Share by Type in 2021
Table Global Metabolic Disorders Drugs Revenue (Million USD) by Type (2017-2022)
Table Global Metabolic Disorders Drugs Revenue Market Share by Type (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue Market Share by Type in 2021
Table Metabolic Disorders Drugs Price by Type (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume and Growth Rate of Tablet (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Tablet (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume and Growth Rate of Injection (2017-2022)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Injection (2017-2022)
Table Global Metabolic Disorders Drugs Consumption by Application (2017-2022)
Table Global Metabolic Disorders Drugs Consumption Market Share by Application (2017-2022)
Table Global Metabolic Disorders Drugs Consumption Revenue (Million USD) by Application (2017-2022)
Table Global Metabolic Disorders Drugs Consumption Revenue Market Share by Application (2017-2022)
Table Global Metabolic Disorders Drugs Consumption and Growth Rate of Diabetes (2017-2022)
Table Global Metabolic Disorders Drugs Consumption and Growth Rate of Disorders of the Thyroid and Pituitary Gland (2017-2022)
Table Global Metabolic Disorders Drugs Consumption and Growth Rate of Other (2017-2022)
Figure Global Metabolic Disorders Drugs Sales Volume and Growth Rate Forecast (2022-2027)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate Forecast (2022-2027)
Figure Global Metabolic Disorders Drugs Price and Trend Forecast (2022-2027)
Figure USA Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure USA Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Europe Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure China Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure China Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Japan Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure India Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure India Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Southeast Asia Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Latin America Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Metabolic Disorders Drugs Market Sales Volume and Growth Rate Forecast Analysis (2022-2027)
Figure Middle East and Africa Metabolic Disorders Drugs Market Revenue (Million USD) and Growth Rate Forecast Analysis (2022-2027)
Table Global Metabolic Disorders Drugs Market Sales Volume Forecast, by Type
Table Global Metabolic Disorders Drugs Sales Volume Market Share Forecast, by Type
Table Global Metabolic Disorders Drugs Market Revenue (Million USD) Forecast, by Type
Table Global Metabolic Disorders Drugs Revenue Market Share Forecast, by Type
Table Global Metabolic Disorders Drugs Price Forecast, by Type
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Tablet (2022-2027)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Tablet (2022-2027)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Injection (2022-2027)
Figure Global Metabolic Disorders Drugs Revenue (Million USD) and Growth Rate of Injection (2022-2027)
Table Global Metabolic Disorders Drugs Market Consumption Forecast, by Application
Table Global Metabolic Disorders Drugs Consumption Market Share Forecast, by Application
Table Global Metabolic Disorders Drugs Market Revenue (Million USD) Forecast, by Application
Table Global Metabolic Disorders Drugs Revenue Market Share Forecast, by Application
Figure Global Metabolic Disorders Drugs Consumption Value (Million USD) and Growth Rate of Diabetes (2022-2027)
Figure Global Metabolic Disorders Drugs Consumption Value (Million USD) and Growth Rate of Disorders of the Thyroid and Pituitary Gland (2022-2027)
Figure Global Metabolic Disorders Drugs Consumption Value (Million USD) and Growth Rate of Other (2022-2027)
Figure Metabolic Disorders Drugs Industrial Chain Analysis
Table Key Raw Materials Suppliers and Price Analysis
Figure Manufacturing Cost Structure Analysis
Table Alternative Product Analysis
Table Downstream Distributors
Table Downstream Buyers
Table Zafgen Profile
Table Zafgen Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Zafgen Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Zafgen Revenue (Million USD) Market Share 2017-2022
Table Mitobridge Profile
Table Mitobridge Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Mitobridge Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Mitobridge Revenue (Million USD) Market Share 2017-2022
Table Biophytis Profile
Table Biophytis Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biophytis Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Biophytis Revenue (Million USD) Market Share 2017-2022
Table OxThera Profile
Table OxThera Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure OxThera Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure OxThera Revenue (Million USD) Market Share 2017-2022
Table CellCentric Profile
Table CellCentric Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure CellCentric Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure CellCentric Revenue (Million USD) Market Share 2017-2022
Table Eternygen Profile
Table Eternygen Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Eternygen Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Eternygen Revenue (Million USD) Market Share 2017-2022
Table Rhythm Profile
Table Rhythm Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Rhythm Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Rhythm Revenue (Million USD) Market Share 2017-2022
Table Verva Pharmaceuticals Profile
Table Verva Pharmaceuticals Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Verva Pharmaceuticals Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Verva Pharmaceuticals Revenue (Million USD) Market Share 2017-2022
Table PerkinElmer Profile
Table PerkinElmer Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure PerkinElmer Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure PerkinElmer Revenue (Million USD) Market Share 2017-2022
Table Pronutria Biosciences Profile
Table Pronutria Biosciences Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Pronutria Biosciences Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Pronutria Biosciences Revenue (Million USD) Market Share 2017-2022
Table Anchor Therapeutics Profile
Table Anchor Therapeutics Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Anchor Therapeutics Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Anchor Therapeutics Revenue (Million USD) Market Share 2017-2022
Table Outpost Medicine Profile
Table Outpost Medicine Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Outpost Medicine Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Outpost Medicine Revenue (Million USD) Market Share 2017-2022
Table Nimbus Therapeutics Profile
Table Nimbus Therapeutics Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Nimbus Therapeutics Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Nimbus Therapeutics Revenue (Million USD) Market Share 2017-2022
Table MedGenome Profile
Table MedGenome Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure MedGenome Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure MedGenome Revenue (Million USD) Market Share 2017-2022
Table Biophytis Profile
Table Biophytis Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Biophytis Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Biophytis Revenue (Million USD) Market Share 2017-2022
Table Zealand Pharma Profile
Table Zealand Pharma Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Zealand Pharma Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Zealand Pharma Revenue (Million USD) Market Share 2017-2022
Table Exelixis, Inc. Profile
Table Exelixis, Inc. Metabolic Disorders Drugs Sales Volume, Revenue (Million USD), Price and Gross Margin (2017-2022)
Figure Exelixis, Inc. Metabolic Disorders Drugs Sales Volume and Growth Rate
Figure Exelixis, Inc. Revenue (Million USD) Market Share 2017-2022
